Form 4: Evolent Health Executive Daniel McCarthy Increases Stake in Company

Daniel Joseph McCarthy, President of Evolent Health, Inc., recently purchased 11,040 shares of Class A Common Stock at an average price of $9.01.

Summary

• On March 6, 2025, Daniel Joseph McCarthy, President of Evolent Health, Inc., acquired 11,040 shares of Class A Common Stock.
• The shares were purchased at a weighted average price of $9.01, with individual prices ranging from $8.74 to $9.34.
• Following the transaction, McCarthy's total beneficial ownership in Evolent Health, Inc. amounts to 389,004 shares, which includes restricted stock units granted under previous awards.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. An executive purchasing shares suggests confidence, but it's a routine filing.

Positives

• The purchase of shares by a company executive can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders. Executive stock purchases are often viewed positively by investors.

Stakeholder Impact

• The stock purchase by a key executive could positively influence shareholder sentiment.

Key Dates